Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex R Hobson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cardiovascular Therapeutics|September 3, 2011
Clopidogrel "resistance": where are we now?Zeshan Qureshi, Alex R Hobson
Cardiovascular Therapeutics|November 12, 2009
Gender and responses to aspirin and clopidogrel: insights using short thrombelastographyAlex R Hobson, Zeshan Qureshi, Phil Banks, et al.
Thrombosis|November 16, 2011
The Potential Value of Near Patient Platelet Function Testing in PCI: Randomised Comparison of 600 mg versus 900 mg Clopidogrel Loading DosesAlex R Hobson, Zeshan Qureshi, Phil Banks, et al.
Platelets|October 9, 2009
Effects of clopidogrel on "aspirin specific" pathways of platelet inhibitionAlex R Hobson, Zeshan Qureshi, Phil Banks, et al.
Platelets|October 25, 2007
A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastographyAlex R Hobson, Graham W Petley, Keith D Dawkins, et al.
Thrombosis Journal|March 4, 2008
Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapyAlex R Hobson, Graham Petley, Geraint Morton, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2011
How should I treat severe calcific coronary artery disease?Juan P Fernandez, Alex R Hobson, Daniel B McKenzie, et al.
The Journal of Invasive Cardiology|April 10, 2008
Malignancy: an unrecognized risk factor for coronary stent thrombosis?Alex R Hobson, Daniel B McKenzie, Vijayalakshmi Kunadian, et al.
The Annals of Thoracic Surgery|December 25, 2007
Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictorsSam Dawkins, Alex R Hobson, Paul R Kalra, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 5, 2013
Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesionsJuan P Fernandez, Alex R Hobson, Daniel McKenzie, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cardiovascular Therapeutics|September 3, 2011
Clopidogrel "resistance": where are we now?Zeshan Qureshi, Alex R Hobson
Cardiovascular Therapeutics|November 12, 2009
Gender and responses to aspirin and clopidogrel: insights using short thrombelastographyAlex R Hobson, Zeshan Qureshi, Phil Banks, et al.
Thrombosis|November 16, 2011
The Potential Value of Near Patient Platelet Function Testing in PCI: Randomised Comparison of 600 mg versus 900 mg Clopidogrel Loading DosesAlex R Hobson, Zeshan Qureshi, Phil Banks, et al.
Platelets|October 9, 2009
Effects of clopidogrel on "aspirin specific" pathways of platelet inhibitionAlex R Hobson, Zeshan Qureshi, Phil Banks, et al.
Platelets|October 25, 2007
A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastographyAlex R Hobson, Graham W Petley, Keith D Dawkins, et al.
Thrombosis Journal|March 4, 2008
Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapyAlex R Hobson, Graham Petley, Geraint Morton, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2011
How should I treat severe calcific coronary artery disease?Juan P Fernandez, Alex R Hobson, Daniel B McKenzie, et al.
The Journal of Invasive Cardiology|April 10, 2008
Malignancy: an unrecognized risk factor for coronary stent thrombosis?Alex R Hobson, Daniel B McKenzie, Vijayalakshmi Kunadian, et al.
The Annals of Thoracic Surgery|December 25, 2007
Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictorsSam Dawkins, Alex R Hobson, Paul R Kalra, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 5, 2013
Beyond the balloon: excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesionsJuan P Fernandez, Alex R Hobson, Daniel McKenzie, et al.
Pageof 1